Similar articles for PMID: 28647091

Year	Number of Results
2001	1
2003	1
2005	2
2006	1
2007	1
2008	1
2009	5
2011	2
2012	2
2013	8
2014	13
2015	15
2016	12
2017	9
2018	4
2019	1
2020	3
2021	3
2022	2
2024	0

1

Phenotypic screening-the fast track to novel antibody discovery.

Minter RR, Sandercock AM, Rust SJ. Minter RR, et al. Drug Discov Today Technol. 2017 Mar;23:83-90. doi: 10.1016/j.ddtec.2017.03.004. Epub 2017 Apr 25. Drug Discov Today Technol. 2017. PMID: 28647091 Review.

2

Phenotypic screening: the future of antibody discovery.

Gonzalez-Munoz AL, Minter RR, Rust SJ. Gonzalez-Munoz AL, et al. Drug Discov Today. 2016 Jan;21(1):150-156. doi: 10.1016/j.drudis.2015.09.014. Epub 2015 Oct 9. Drug Discov Today. 2016. PMID: 26440132 Review.

3

Target Identification of Compounds from a Cell Viability Phenotypic Screen Using a Bead/Lysate-Based Affinity Capture Platform.

Tang H, Duggan S, Richardson PL, Marin V, Warder SE, McLoughlin SM. Tang H, et al. J Biomol Screen. 2016 Feb;21(2):201-11. doi: 10.1177/1087057115622431. Epub 2015 Dec 16. J Biomol Screen. 2016. PMID: 26676096

4

The Use of Antibodies in Small-Molecule Drug Discovery.

Marsden CJ, Eckersley S, Hebditch M, Kvist AJ, Milner R, Mitchell D, Warwicker J, Marley AE. Marsden CJ, et al. J Biomol Screen. 2014 Jul;19(6):829-38. doi: 10.1177/1087057114527770. Epub 2014 Apr 2. J Biomol Screen. 2014. PMID: 24695620 Review.

5

Cell and small animal models for phenotypic drug discovery.

Szabo M, Svensson Akusjärvi S, Saxena A, Liu J, Chandrasekar G, Kitambi SS. Szabo M, et al. Drug Des Devel Ther. 2017 Jun 28;11:1957-1967. doi: 10.2147/DDDT.S129447. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28721015 Free PMC article. Review.

6

New horizons in therapeutic antibody discovery: opportunities and challenges versus small-molecule therapeutics.

Smith AJ. Smith AJ. J Biomol Screen. 2015 Apr;20(4):437-53. doi: 10.1177/1087057114562544. Epub 2014 Dec 15. J Biomol Screen. 2015. PMID: 25512329 Review.

7

Phenotypic screens targeting neurodegenerative diseases.

Zhang M, Luo G, Zhou Y, Wang S, Zhong Z. Zhang M, et al. J Biomol Screen. 2014 Jan;19(1):1-16. doi: 10.1177/1087057113499777. Epub 2013 Aug 19. J Biomol Screen. 2014. PMID: 23958650 Review.

8

Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling.

Sandercock AM, Rust S, Guillard S, Sachsenmeier KF, Holoweckyj N, Hay C, Flynn M, Huang Q, Yan K, Herpers B, Price LS, Soden J, Freeth J, Jermutus L, Hollingsworth R, Minter R. Sandercock AM, et al. Mol Cancer. 2015 Jul 31;14:147. doi: 10.1186/s12943-015-0415-0. Mol Cancer. 2015. PMID: 26227951 Free PMC article.

9

Antibody-based technologies for target discovery.

Valle RP, Jendoubi M. Valle RP, et al. Curr Opin Drug Discov Devel. 2003 Mar;6(2):197-203. Curr Opin Drug Discov Devel. 2003. PMID: 12669455 Review.

10

The future for early-stage tuberculosis drug discovery.

Zuniga ES, Early J, Parish T. Zuniga ES, et al. Future Microbiol. 2015;10(2):217-29. doi: 10.2217/fmb.14.125. Future Microbiol. 2015. PMID: 25689534 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year